Treatment of a newly diagnosed glioblastoma harboring MET amplification with vebreltinib in combination with radiotherapy: a case report
Abstract MET-amplified glioblastoma (GBM) is rare, accounting for approximately 2–5% of cases. However, the treatment regimens for patients with MET-amplified GBM still have not reached a unanimous consensus. Our paper describes the use of vebreltinib in a newly diagnosed glioblastoma patient harbor...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Discover Oncology |
| Online Access: | https://doi.org/10.1007/s12672-025-02979-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|